Research Article |
Corresponding author: Winarto Haryadi ( wnrt_haryadi@ugm.ac.id ) Academic editor: Magdalena Kondeva-Burdina
© 2023 Anselmania Kartini Dhey, Eka Rasuna Andriani, Berliana Mardawati, Bunga Nur Annisa, Rhesi Kristiana, Vera Permatasari, Gian Primahana, Muhammad Eka Prastya, Puspa Dewi Narrij Lotulung, Tjandrawati Mozef, Akhmad Darmawan, Sofa Fajriah, Chairil Anwar, Winarto Haryadi.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Dhey AK, Andriani ER, Mardawati B, Annisa BN, Kristiana R, Permatasari V, Primahana G, Prastya ME, Lotulung PDN, Mozef T, Darmawan A, Fajriah S, Anwar C, Haryadi W (2023) Isolation and activity test of antioxidant, antibacterial, and cytotoxic compounds from the stem bark of Aglaia foveolata Pannell. Pharmacia 70(4): 1329-1334. https://doi.org/10.3897/pharmacia.70.e111111
|
Aglaia foveolata Pannell (A. foveolata) is a type of plant that has many benefits, including the skin, leaves, roots, and seeds as medicinal ingredients. The potential of this plant is inseparable from the content of various bioactive compounds. This study aims to isolate, characterize the active compound from the stem bark of A. foveolata and test its activity as an antioxidant with the ABTS method, cytotoxic (MCF-7 cancer cells) with the MTT method, and antibacterial (bacterial strains ATCC and MDR) with the MIC. There are four isolated compounds obtained, namely (1) 17,24-epoxy-25-hydroxybaccharan-3-one, (2) β-stigmasterol glucoside, (3) Eichlerianic acid, and (4) 17,24-epoxy-25 -hydroxy-3- oxobaccharan-21-oic acid, which is a class of triterpenoid and steroid compounds. The best activity as an antioxidant was compound 3 (25.68 µg/mL); cytotoxic activity against MCF-7 cells namely compound 4 (94.59 µg/mL); antibacterial activity against ATCC strains: (1) P. aeruginosa namely compound 3 (29.4 µg/mL), (2) E. coli, (3) S. aureus, (4) B. subtilis for compounds 1, 2, and 4 have the same activity (62.5 µg/mL) while compound 3 was not active; MDR bacterial strains: (1) P. aeruginosa namely compound 4 (62.5 µg/mL), (2) E. coli namely compound 3 (62.5 µg/mL), (3) S. aureus namely compound 4 (62 .5 µg/mL), (4) B. subtilis namely compound 4 (62.5 µg/mL) and (5) K. pneumoniae namely compound 1 (125 µg/mL).
Aglaia foveolata, triterpenoid, antioxidant, cytotoxic, antibacterial
Indonesia, a megabiodiversity country, has the second biggest biodiversity in the world (
Previous phytochemical studies of the species Aglaia foveolata reported some variety of compounds from leaves, bark and stem bark including flavaglines (e.g. silvestrol, bisamides, and rocaglamides) and dammarane-type triterpenoid (
The bark of A. foveolata was collected from Mekongga forest, Southeast Sulawesi, Indonesia. The sample was identified by a botanist at Herbarium Bogoriense (collection number SR-IS-22).
2.8 kg of dried samples of dried stem bark of A. foveolata were extracted by maceration method using 70% ethanol at room temperature for 3 days. The EtOH extract was concentrated in vacuum at ± 40 °C and 150 g crude extract was obtained. The crude extract was suspended in H2O: MeOH (7: 3, 300 mL) to give an aqueous solution. The extract was continued by partitioning using the same volume of n-hexane solvent, then concentrated, followed by ethyl acetate (EtOAc), and n-butanol (BuOH). Evaporation produced crude extracts of n-hexane (63.36 g), EtOAc (61.83 g), n-BuOH (24.6 g), and residue H2O (0.21 g). The cytotoxic activity of all extracts was evaluated against MCF-7 breast cancer cells, and the EtOAc extract showed the strongest cytotoxic activity. Therefore, the phytochemical analysis was focused on the EtOAc extract.
The EtOAc extract (48.7 g) was separated by column chromatography using silica gel (stationary phase) and the eluent (mobile phase) of a mixture of n-hexane:EtOAc (10:0–0:10), so that 75 fractions (F1–F75) were obtained. The TLC profiles of the fractions monitored by LC produced F2, F15, F17, and F21. This fraction was tested for cytotoxic activity, and fractions F15 and F21 showed the strongest activity, so further purification was carried out. The F8 and F38 fractions were identified based on the spectroscopic method as pure compounds, yielding 17,24-epoxy-25-hydroxy-baccharan-3-one (1) (0.3 g) and stigmast-5,22-dien-3β-ol- 3-O-β-D-glucopyranoside (2) (0.1 g).
The F15 fraction was subjected to CC on a silica gel using a gradient elution mixture of n-hexane: EtOAc (10:0–0:10) to produce the subfractions (A–J). Subfraction J (60 mg) was chromatographed on a preparative RP-18 column (SupelcosilTM PLC 18 column (25 cm × 21.2 mm, 12 µm)), using isocratic conditions (CH3CN-H2O, 30:70) resulting in the purification of the eichlerianic acid compound (3) (12.2 mg, tR 9.97 minutes). Similarly, the compound 17,24-epoxy-25-hydroxy-3-oxobaccharan-21-oic acid (4) (10.1 mg, tR 8.05 minutes) was obtained from the F21 fraction (20 mg) using a SupelcosilTM PLC 18 column (25 cm × 21.2 mm, 12 µm); CH3CN-H2O, 55:45).
17,24-epoxy-25-hydroxybaccharan-3-one (1): forms a colorless needle pattern; UV (MeOH) λmax (log ε) 205 nm; IR (KBr) νmax: 3501, 1697, 1453, 1377, 1082, 895 cm-1; 1H and 13C NMR (500/126 MHz, chloroform-d), see Table
Position | 1a | 2b | 3c | 4a | ||||
---|---|---|---|---|---|---|---|---|
δH | δC | δH | δC | δH | δC | δH | δC | |
1 | 1.44, 1.93 | 39.9 | 1.93 | 33.4 | 1.39, 1.95 | 35.8 | 1.39, 1.95 | 39.9 |
2 | 2.44, 2.51 | 34.2 | 2.34, 2.90 | 31.4 | 2.33, 2.14 | 30.0 | 2.41, 2.51 | 34.3 |
3 | - | 218.4 | 3.12 | 76.9 | - | 178.9 | - | 218.2 |
4 | - | 71.3 | 3.05 | 38.4 | - | 149.1 | - | 47.5 |
5 | 1.33 | 50.2 | - | 140.5 | 2.07 | 51.7 | 1.37 | 55.2 |
6 | 1.47, 1.79 | 22.1 | 5.32 s | 121.3 | 1.72, 1.84 | 26.1 | 1.49, 1.53 | 19.7 |
7 | 1.40 | 31.3 | 1.80 | 29.3 | - | 35.3 | 1.43 | 33.0 |
8 | - | 40.4 | 1.64 | 31.5 | - | 41.4 | - | 42.7 |
9 | 1.43 | 50.0 | 1.09 | 49.7 | 1.29, 1.37 | 42.5 | 1.47 | 50.0 |
10 | - | 36.9 | - | 36.3 | - | 40.3 | - | 37.1 |
11 | 1.31, 1.53 | 25.9 | 1.46 | 22.7 | - | 23.6 | 1.36, 1.62 | 21.0 |
12 | 1.11, 1.96 | 26.1 | 1.36 | 36.9 | - | 28.3 | 1.16, 2.04 | 24.1 |
13 | 1.74 | 43.1 | - | 41.9 | 1.58, 1.71 | 44.4 | 1.83 | 40.4 |
14 | - | 47.5 | 1.15 | 56.2 | - | 52.0 | - | 40.9 |
15 | 0.97, 1.64 | 27.1 | 1.50 | 25.4 | - | 32.7 | 1.25, 1.52 | 28.3 |
16 | 1.34 | 34.7 | 1.62 | 27.9 | 1.57, 1.69 | 27.0 | 1.12, 2.22 | 30.8 |
17 | 3.64 t | 55.4 | 1.20 | 55.5 | - | 51.3 | 4.04 | 76.1 |
18 | 1.08 s | 16.1 | 0.64 s | 11.9 | 0.88 s | 17.0 | 0.96 s | 15.7 |
19 | 0.93 s | 16.2 | 0.95 s | 19.8 | 0.95 s | 21.0 | 0.93 s | 16.0 |
20 | - | - | 1.40 | 35.6 | - | 88.0 | - | 47.3 |
21 | 0.99 s | 21.1 | 1.00 | 19.0 | 1.15 s | 26.3 | - | 176.8 |
22 | 1.38, 1.52 | 37.7 | 4.92 | 138.1 | 1.83, 1.90 | 36.3 | 1.78, 1.99 | 32.1 |
23 | 1.45, 1.75 | 19.8 | 5.16 | 128.9 | - | 27.9 | 1.89, 2.01 | 20.4 |
24 | 3.76 t | 84.6 | 1.13 | 45.2 | 3.68 t | 87.9 | 3.71 t | 79.6 |
25 | - | 86.6 | 1.60 | 28.7 | - | 72.2 | - | 75.5 |
26 | 1.14 s | 24.4 | 0.81 | 19.2 | 1.16 s | 27.6 | 1.30 s | 27.3 |
27 | 1.20 s | 27.8 | 0.80 | 18.7 | 1.13 s | 25.8 | 1.21 s | 28.1 |
28 | 1.10 s | 26.2 | 1.26 | 23.9 | 4.70, 4.85 | 114.1 | 1.05 s | 26.7 |
29 | 1.03 s | 21.8 | 0.90 d | 12.2 | 1.76 s | 24.0 | 1.01 s | 21.2 |
30 | 0.87 s | 15.3 | 1.07 s | 16.0 | 0.95 s | 15.3 | ||
Glc | ||||||||
1´ | 4.89 | 100.8 | ||||||
2´ | 3.65 | 73.5 | ||||||
3´ | 3.52 | 76.8 | ||||||
4´ | 3.48 | 70.1 | ||||||
5´ | 4.22 | 76.8 | ||||||
6´ | 4.47 t | 61.1 t |
Stigmast-5,22-dien-3β-ol-3-O-β-D-glucopyranoside (2): colorless needles; UV (MeOH) λmax (log ε) 205 nm; IR (KBr) νmax 3381, 1459, 1370, 1018 cm-1; 1H and 13C NMR (500/126 MHz, dmso-d6), see Table
Eichlerianic acid (3): oily needles; UV (MeOH) λmax (log ε) 205 (4.297) nm; IR (KBr) νmax 3509, 1699, 1451, 1379, 1029 cm-1; 1H and 13C NMR (500/126 MHz, methanol-d4), see Table
17,24-epoxy-25-hydroxy-3-oxobaccharan-21-oic acid (4): amorphous solid; UV (MeOH) λmax (log ε) 205 nm; IR (KBr) νmax 3508, 1749, 1696, 1448, 1334, 1031 cm-1.; 1H and 13C NMR (500/126 MHz, chloroform-d), see Table
The radical scavenging activity of the isolated compounds was determined using the modified ABTS (2,2’-azinobis-3-ethylbenzothiazoline-6-sulfonic acid) decolorization method using a 96-well plate (
ABTS•+ scavenging activity = [(Acontrol − Asample) / Acontrol] × 100%
Antioxidant activity data were presented as IC50 values and obtained through a linear regression curve.
The isolated compounds were tested against breast cancer cells (MCF-7) using the MTT method (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) in 96-well microplates. Briefly, cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% (v/v) Fetal Bovine Serum (FBS) and Antibiotic-antimycotic. After 24 h of incubation, cells were treated with different concentrations of all compounds (6.25, 12.50, 25, 50, and 100 µg/mL), and doxorubicin (Sigma, St. Louis, MO) was used as a positive control. The test was stopped after an incubation period of 48 hours by adding 10 μL of MTT reagent and then incubated for 4 hours at 37 °C. The medium was carefully removed, and the cells were dissolved in 100 μL DMSO as a reaction stop. Absorbance was read with a microplate reader at a wavelength of 570 nm. The IC50 value was calculated using the linear regression method using Microsoft Excel software.
Evaluation of antibacterial activity using ATCC bacteria and clinically isolated MDR bacterial strains, including two gram-positive bacteria (Staphylococcus aureus (S. aureus) ATCC 6538 and Bacillus subtilis (B. subtilis) ATCC 19659) and two gram-negative bacteria (Escherichia coli (E. coli) ATCC 8739 and Pseudomonas aeruginosa (P. aeruginosa) ATCC 15442), and multiresistant isolates from S. aureus, B. subtilis strain M18, P. aeruginosa strain M19, E. coli strain M4, and Klebsiella pneumoniae (K. pneumoniae) strain M19. This bacterium was isolated from the Central General Hospital (RSUP), Doctor Kariadi, Semarang, Central Java (R. Kristiana Collection, MERO Foundation, Bali). The Minimum Inhibitory Concentration (MIC) value of the isolated compound was measured using a standard microdilution test with slight modifications (
Ethyl acetate fraction of the stem bark of A. foveolata afforded three known triterpenes and steroid including 17,24-epoxy-25-hydroxybaccharan-3-one (1) (
These compounds were evaluated for their cytotoxic activity against the MCF-7 human breast cancer, antioxidant (Table
Compound | ABTS | MCF-7 | |
---|---|---|---|
IC50 (µg/mL) | Inhibition (%) | IC50 (µg/mL) | |
1 | 187.18 | 34.73 ± 2.79 | 175.11 |
2 | 62.87 | 10.13 ± 4.22 | 446.87 |
3 | 25.68 | 7.92 ± 4.32 | 535.11 |
4 | 54.50 | 44.77 ± 7.30 | 94.59 |
Doxorubicin | - | 91.56 ± 0.18 | - |
Trolox | 18.02 | - | - |
Sample | Bacterial tested | |||
---|---|---|---|---|
P. aeruginosa | E. coli | S. aureus | B. subtilis | |
MIC (µg/mL) | ||||
1 | 125 | 62.5 | 125 | 125 |
2 | 62.5 | 62.5 | 125 | 125 |
3 | 29.4 | - | - | - |
4 | 62.5 | 62.5 | 62.5 | 62.5 |
Tetracycline (Control) | 3.90625 | 3.90625 | 3.90625 | 3.90625 |
Sample | Bacterial tested | ||||
P. aeruginosa | E. coli | S. aureus | B. subtilis | K. pneumoniae | |
MIC (µg/mL) | |||||
1 | 250 | 250 | 250 | 250 | 125 |
2 | 250 | 250 | 250 | 250 | 250 |
3 | - | 62.5 | 125 | 125 | 250 |
4 | 62.5 | 125 | 62.5 | 62.5 | 250 |
Tetracycline (Control) | 3.90625 | 3.90625 | 3.90625 | 3.90625 | 3.90625 |
The relative antioxidant ability to scavenge the radical ABTS•+ has been compared to positive control Trolox and is an outstanding method for determining the antioxidant activity of hydrogen-donating antioxidants. As shown in Table
The cytotoxic effect on the MCF-7 breast cancer line was measured using a standard MTT assay compared to Doxorubicin as positive control. Among the four compounds, 17,24-epoxy-25-hydroxybaccharan-3-on (1) and 17,24-epoxy-25-hydroxy-3-oxobaccharan-21-oic acid (4) showed moderate activity, whereas β-stigmasterol glucoside (2) and eichlerianic acid (3) showed weak or no activity. This indicated that the presence of sugar moiety may decrease cytotoxic activity (
The antibacterial activities of the isolated compounds were evaluated against normal ATCC and MDR bacterial strains (Tables
Dammarane and baccharane-type triterpenoids and stigmasterol-glucoside were isolated from the stems bark of A. foveolata. Compound 3 showed the strongest ABTS radical cation scavenging activities, and compound 2–4 exhibited strong activity. For cytotoxic activity, baccharanes compound 1 and 4 showed moderate activity against MCF-7. In addition, antibacterial assay showed all the compounds exhibited strong activity against normal and MDR bacterial strains, while compound 3 showed strongest activity against P. aeruginosa-normal strains. To the best our knowledge, this is the first report of triterpenoid of A. foveolata as antioxidants and antibacterial.
This work was supported by Rumah Program Vaksin Obat, Organisasi Riset Kesehatan, fiscal year 2023, National Research and Innovation Agency (BRIN). Moreover, we are thankful to Final Project Recognition Grant Universitas Gadjah Mada Number 5075/UN1.P.II/Dit-Lit/PT.01.01/2023, for the financial support. The authors highly appreciated the facilities, scientific and technical support for spectroscopic data measurements from Advanced Characterization Laboratories Serpong through E-Layanan Sains, National Research and Innovation Agency (BRIN).